CSF3 and Hepatic fibrosis: The study found that the effects in the BMSCs+G-CSF and BMSCs+JSSQ groups on the pathological scores of LN, PCIII, CIV, and liver cirrhosis after therapy were significant, with no significant difference between groups, indicating that the BMSCs+JSSQ group had a significant effect on hepatic fibrosis, hepatocyte steatosis, and inflammation necrosis in cirrhotic rats.